Dialysis Providers Gain as Investors Focus on Cardiac Benefits After Ozempic ' s Latest Data Dialysis Providers Gain as Investors Focus on Cardiac Benefits After Ozempic ' s Latest Data

Shares of dialysis services providers jumped between 3% and 12% on Tuesday as latest data from Novo Nordisk ' s hugely popular diabetes drug Ozempic indicated a...Reuters Health Information
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Nephrology Source Type: news